Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: β23P: Early pembrolizumab clearance as a sensitive prognostic biomarker for survival in patients with advanced non-small cell lung cancerβ.
L.-S. Otten, F. de Vries, Eric J. F. Franssen, Berber Piet, Andries J. Smit +2 more